NanoString TechnologiesAktie

ISIN: US63009R1095 | WKN: A1W1X2 | Symbol: NSTG
38,34
 
USD
02:00:00 Nasdaq
-3,40 %
-1,35 USD
Geldkurs 20.10.20
38,32 USD
4.900 Stk.
Briefkurs 20.10.20
38,34 USD
2.700 Stk.
Mehr Daten anzeigen
Smartbroker
NewsFlashAnzeige
Nach dem Mega-Deal mit Newmont folgt der nächste Paukenschlag! Hochgradige Goldfunde sorgen für Neubewertung!

NanoString Technologies Chart

Neuigkeiten zur NanoString Technologies Inc Aktie

ZeitTitel
SmartbrokerJetzt auf smartbroker.de - ab 0 € pro Order handeln! Anzeige
13.10.20
NanoString Technologies Announces Closing of Public Offering of $230.0 Million of Common Stock Including Exercise in Full of Option to Purchase Additional Shares
08.10.20
OnRamp Bio and NanoString Announce Global Availability of ROSALIND for nCounter Users
08.10.20
NanoString Technologies Announces Pricing of Upsized Public Offering of $200 Million of Common Stock
06.10.20
NanoString Technologies Announces Commencement of Public Offering of Common Stock
06.10.20
NanoString Technologies Provides Preliminary Financial and Operational Highlights for Third Quarter 2020
05.10.20
NanoString to Release Third Quarter 2020 Operating Results and Host Conference Call on Monday, November 9, 2020
14.09.20
NanoString Launches Whole Transcriptome Atlas under GeoMx Technology Access Program and Names First GeoMx Premier Access Sites
09.09.20
NanoString to Present at the 18th Annual Morgan Stanley Global Healthcare Conference
09.09.20
NanoString Announces New GeoMx COVID-19 Consortium, Part of the GeoMx Translational Leadership Network
03.09.20
NanoString to Present at the 2020 Baird Global Healthcare Conference
10.08.20
NanoString Technologies Releases Operating Results for Second Quarter of 2020
06.08.20
NanoString and Bio-Techne Announce Offering of RNAscope Reagents Validated for Use With the GeoMx Digital Spatial Profiler
03.08.20
NanoString Extends Leadership in Spatial Genomics with Launch of GeoMx DSP Read-Out for Next Generation Sequencers
08.07.20
NanoString to Release Second Quarter 2020 Financial Results and Host Conference Call on Monday, August 10, 2020
Insidertrade: :
Hier Upload von Dokumenten / Links zum Wertpapier: Upload

Nachrichten aus der Branche Biotechnologie

ZeitTitel
20.10.20
Oncocyte Announces Third Quarter Growth of DetermaRx Physician Adoption and Testing Volume
20.10.20
Eargo, Inc. Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
20.10.20
Harvard Bioscience Schedules Third Quarter 2020 Earnings Conference Call for November 5, 2020 at 8: 00 AM ET
20.10.20
Alexion to Report Third Quarter 2020 Results on Thursday, October 29, 2020
20.10.20
Roche and Prothena will Advance Prasinezumab into Late-Stage Clinical Development Study in Parkinson’s Disease
mehr Branchennachrichten »

Aktienkurs NanoString Technologies A1W1X2 |

BörsenplatzNasdaq
Letzter Kurs38,34USD
Performance-3,40 %
Kurszeit02:00:00
Eröffnung39,44USD
Tageshoch40,67USD
Tagestief37,87USD
Vortageskurs39,69USD
Volumen1,37 Mio.Stk.
52-Wochen Hoch46,93USD
52-Wochen Tief13,850USD
Anzahl Trades5.994
Performance 1 Monat-9,52 %
Performance 1 Jahr+81,21 %

Stammdaten zu NanoString Technologies

NameNanoString Technologies Inc
KurznameNanoString Tech
NamenszusatzRegistered Shs
KategorieAktien
AktientypStammaktien
WKNA1W1X2
SymbolNSTG
BrancheBiotechnologie
LandUSA USA
ReferenzwährungUSD
Aktienanzahl43,74 Mio.
Marktkapitalisierung1,68 Mrd.USD

Performance NanoString Technologies Aktie

ZeitKursPerf.
1 Tag38,34USD
-3,40 %
1 Woche40,67USD
-1,12 %
1 Monat44,44USD
-9,52 %
3 Monate37,47USD
+7,31 %
6 Monate29,58USD
+35,94 %
Lfd. Jahr27,82USD
+44,54 %
1 Jahr22,190USD
+81,21 %
3 Jahre10,390USD
+287,01 %
5 Jahre15,470USD
+159,92 %
mehr Performancedaten »
Adresse und Kontaktdaten
NameNanoString Technologies Inc
StadtSeattle, Wa
LandUSA USA
Aktionäre interessieren sich auch für:
#WertpapierPerf. %
1.
Amgen
+0,17
2.
Dexcom
-1,28
3.
Immunomedics
+0,13
4.
Merck
+0,65
5.
FT NYSE Arc Bio First Trust NYSE Arca Biotechnology Index Fund
-0,60
6.
Omeros
+1,62
7.
Xencor
-0,47
8.
Horizon Therapeutics
-5,54
9.
CRISPR Therapeutics
-1,25
10.
Seattle Genetics
-0,10

Emissionsinformationen

Emissionspreis10,000USD
Emissionsvolumen5.400.000Stück
ZeichnungsgebührNein
IPO Anmeldetag20.05.2013
IPO26.06.2013
PlatzierungÖffentlich